Base
HTS 3001Chapter 30

HTS 3001 — Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: Duty Rate & Import Guide

Pharmaceutical Products · 13 pending regulations · 15 court cases · Updated daily from USITC

Duty Rates

General

Free

Special

Free

Column 2

Free

Trade Agreement Eligibility

CUSMAKORUS

Trade Intelligence

Regulatory Pressure

HIGH

0 rulings — · 13 reg · 8 CIT, 7 CAFC (2 recent)

Global Rates

🇺🇸 Free

🇬🇧 United Kingdom: N/A · 🇪🇺 European Union: N/A · 🇨🇦 Canada: N/A · 🇧🇷 Brazil: N/A

Compare All →

Data compiled from USITC HTS, Federal Register, CourtListener · As of 2026-06-13 · Updates weekly

Active DisputesRecent court cases or pending regulations affect this code
Regulatory Pressure

This code has elevated regulatory activity — 0 CBP rulings (0 in last 2 years, trend: stable), 13 pending Federal Register actions, and 15 CIT/CAFC cases.

Subheadings (6)

CodeDescriptionRate
3001.20.00.00Extracts of glands or other organs or of their secretionsFree
3001.90.01OtherFree
3001.90.01.10Liver—
3001.90.01.50Other—
3001.90.01.65Heparin—
3001.90.01.95Other—

Federal Register (13)

Notice2019-10191
2019-05-17

Request for Comments Concerning Proposed Modification of Action Pursuant to Section 301: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

Request for comments and notice of public hearing.

Notice2018-15090
2018-07-17

Request for Comments Concerning Proposed Modification of Action Pursuant to Section 301: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

Request for comments and notice of public hearing.

Presidential Document2010-32610
2010-12-27

To Take Certain Actions Under the African Growth and Opportunity Act, and for Other Purposes

Notice2010-14236
2010-06-15

Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS

Institution of investigation and invitation to file written submissions.

Presidential DocumentE8-31137
2008-12-30

To Implement the Dominican Republic-Central America- United States Free Trade Agreement With Respect to Costa Rica and for Other Purposes

View all 13+ regulations on Federal Register →

Court of International Trade & Federal Circuit (15)

Nutricia North America, Inc. v. United States2025-11-17
24-1436Court of Appeals for the Federal Circuit
Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC2024-12-20
24-1936Court of Appeals for the Federal Circuit
Nagase & Co. v. United States2023-04-11
21-00574United States Court of International Trade
Janssen Ortho, LLC v. United States2021-04-26
20-1663Court of Appeals for the Federal Circuit
Janssen Ortho LLC v. United States2020-02-06
13-00296United States Court of International Trade
View all 15+ cases on PACER →

Matching Export Code (Schedule B)

3001200000Schedule B

EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS

Census Bureau export classification matching this HTS import code.

3001.20.00.00 →